CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020

May 20, 2020

CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction

May 20, 2020

CV Sciences, Inc. Reports First Quarter 2020 Financial Results

May 8, 2020

CV Sciences, Inc. to Announce First Quarter 2020 Results on May 8, 2020

Apr 30, 2020

CV Sciences, Inc. Announces Filing of Form S-3 Shelf Registration Statement

Apr 22, 2020

CV Sciences, Inc. Receives Notice of Patent Allowance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction

Apr 6, 2020

CV Sciences, Inc. Reports Fiscal Year-End 2019 Financial Results

Mar 16, 2020

CV SCIENCES, INC. RESCHEDULES FULL YEAR 2019 RESULTS CONFERENCE CALL TO MARCH 16, 2020

Mar 10, 2020

CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020

Feb 26, 2020

CV Sciences, Inc. Launches Updated +PlusCBD™ Oil Website to Enhance User Experience and Drive Increased E-Commerce Sales

Jan 23, 2020